• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过先进的计算药理学方法鉴定有效的食物成分作为 SARS-CoV-2 木瓜蛋白酶样蛋白酶调节剂。

Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches.

机构信息

Department of Chemical Technology, University of Calcutta, 92, A.P.C. Road, Kolkata, 700009, India.

Department of Chemical Technology, University of Calcutta, 92, A.P.C. Road, Kolkata, 700009, India.

出版信息

J Mol Graph Model. 2022 Mar;111:108113. doi: 10.1016/j.jmgm.2021.108113. Epub 2021 Dec 21.

DOI:10.1016/j.jmgm.2021.108113
PMID:34959151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8688376/
Abstract

The current ongoing pandemic of COVID-19 urges immediate treatment measures for controlling the highly contagious SARS-CoV-2 infections. The papain-like protease (PLpro), which is released from nsp3, is presently being evaluated as a significant anti-viral drug target for COVID-19 therapy development. Particularly, PLpro is implicated in the cleavage of viral polyproteins and antagonizes the host innate immune response through its deubiquitinating and deISGylating actions, thus making it a high-profile antiviral therapeutic target. The present study reports a few specific food compounds that can bind tightly with the SARS-CoV-2 PLpro protein identified through extensive computational screening techniques. Precisely, extensive advanced computational approaches combining target-based virtual screening, particularly employing sub-structure based similarity search, molecular docking, molecular dynamics (MD) simulations, and MM-GBSA based binding free energy calculations have been employed for the identification of the most promising food compounds with substantial functional implications as SARS-CoV-2 PLpro protein inhibitors/modulators. Observations from the present research investigation also provide a deeper understanding of the binding modes of the proposed four food compounds with SARS-CoV-2 PLpro protein. In docking analyses, all compounds have established essential inter-molecular interaction profiles at the active site cavity of the SARS-CoV-2 PLpro protein. Similarly, the long-range 100 ns conventional MD simulation studies also provided an in-depth understanding of probable interactions and dynamic behaviour of the SARS-CoV-2 PLpro protein-food compound complexes. Binding free energies of all molecular systems revealed a strong interaction affinity of food compounds towards the SARS-CoV-2 PLpro protein. Moreover, clear-cut comparative analyses against the known standard inhibitor also suggest that proposed food compounds may act as potential active chemical entities for modulating the action of the SARS-CoV-2 PLpro protein.

摘要

当前 COVID-19 的大流行迫切需要采取治疗措施来控制高传染性的 SARS-CoV-2 感染。目前,从 nsp3 释放的木瓜蛋白酶样蛋白酶(PLpro)被评估为 COVID-19 治疗开发的重要抗病毒药物靶标。特别是,PLpro 参与病毒多蛋白的切割,并通过去泛素化和去 ISGylating 作用拮抗宿主先天免疫反应,因此成为一个备受关注的抗病毒治疗靶标。本研究通过广泛的计算筛选技术,报告了一些可以与 SARS-CoV-2 PLpro 蛋白紧密结合的特定食物化合物。具体来说,采用了广泛的先进计算方法,包括基于靶标的虚拟筛选,特别是基于子结构的相似性搜索、分子对接、分子动力学(MD)模拟和基于 MM-GBSA 的结合自由能计算,用于鉴定具有重要功能意义的最有前途的食物化合物作为 SARS-CoV-2 PLpro 蛋白抑制剂/调节剂。本研究还提供了对所提出的四种食物化合物与 SARS-CoV-2 PLpro 蛋白结合模式的更深入理解。在对接分析中,所有化合物在 SARS-CoV-2 PLpro 蛋白的活性位点腔中都建立了重要的分子间相互作用模式。同样,长达 100 ns 的常规 MD 模拟研究也深入了解了 SARS-CoV-2 PLpro 蛋白-食物化合物复合物的可能相互作用和动态行为。所有分子系统的结合自由能揭示了食物化合物对 SARS-CoV-2 PLpro 蛋白的强烈相互作用亲和力。此外,与已知标准抑制剂的明确比较分析表明,所提出的食物化合物可能作为调节 SARS-CoV-2 PLpro 蛋白作用的潜在有效化学实体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/523de36985b1/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/938b3d2fd772/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/601f32ea4336/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/733b3d92eee6/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/6c5b755a05fa/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/4f1b8dffea24/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/071c530b7ee8/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/0d11c39a61d4/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/7c236507a230/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/9225306a232c/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/439f03aebc20/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/523de36985b1/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/938b3d2fd772/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/601f32ea4336/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/733b3d92eee6/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/6c5b755a05fa/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/4f1b8dffea24/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/071c530b7ee8/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/0d11c39a61d4/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/7c236507a230/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/9225306a232c/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/439f03aebc20/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf1/8688376/523de36985b1/gr10_lrg.jpg

相似文献

1
Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches.通过先进的计算药理学方法鉴定有效的食物成分作为 SARS-CoV-2 木瓜蛋白酶样蛋白酶调节剂。
J Mol Graph Model. 2022 Mar;111:108113. doi: 10.1016/j.jmgm.2021.108113. Epub 2021 Dec 21.
2
Identification of bio-active food compounds as potential SARS-CoV-2 PLpro inhibitors-modulators via negative image-based screening and computational simulations.通过基于负像的筛选和计算模拟鉴定具有生物活性的食物化合物作为潜在的 SARS-CoV-2 PLpro 抑制剂调节剂。
Comput Biol Med. 2022 Jun;145:105474. doi: 10.1016/j.compbiomed.2022.105474. Epub 2022 Apr 1.
3
Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations.新型冠状病毒2型木瓜样蛋白酶的分子模拟:同源建模、分子对接和分子动力学模拟的综合研究
SAR QSAR Environ Res. 2021 Sep;32(9):699-718. doi: 10.1080/1062936X.2021.1960601. Epub 2021 Aug 16.
4
Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study.基于微生物的天然化合物作为 SARS-CoV-2 木瓜蛋白酶样蛋白酶 (PLpro) 的潜在抑制剂:分子对接和动态模拟研究。
J Biomol Struct Dyn. 2022;40(24):13848-13858. doi: 10.1080/07391102.2021.1997815. Epub 2021 Nov 3.
5
Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations.探索大麻素作为 SARS-CoV-2 木瓜样蛋白酶潜在抑制剂的研究:基于计算分析和分子动力学模拟的见解。
Viruses. 2024 May 30;16(6):878. doi: 10.3390/v16060878.
6
Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.针对 SARS-CoV-2 的 PLPro 对氯喹和羟氯喹结合的计算研究。
J Biomol Struct Dyn. 2022 Apr;40(7):3071-3081. doi: 10.1080/07391102.2020.1844804. Epub 2020 Nov 17.
7
Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA.使用虚拟筛选、分子对接、动力学和 MMPBSA 研究 SARS-CoV-2 的 PLpro 的有前途的抗病毒药物。
J Biomol Struct Dyn. 2023 Jul;41(10):4650-4666. doi: 10.1080/07391102.2022.2071340. Epub 2022 May 5.
8
A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2.采用计算本质动力学方法研究 SARS-CoV-2 木瓜蛋白酶样蛋白酶配体结合对结构的影响。
Comput Biol Chem. 2022 Aug;99:107721. doi: 10.1016/j.compbiolchem.2022.107721. Epub 2022 Jun 28.
9
screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.筛选植物多酚类化合物,以鉴定新型蛋白酶抑制剂,有效对抗 SARS-CoV-2。
J Biomol Struct Dyn. 2022;40(20):10437-10453. doi: 10.1080/07391102.2021.1944909. Epub 2021 Jun 28.
10
Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.红茶生物活性成分抑制 SARS-CoV-2 的多个靶点(3CLpro、PLpro 和 RdRp):虚拟筛选和分子动力学模拟研究。
J Biomol Struct Dyn. 2022 Sep;40(15):7143-7166. doi: 10.1080/07391102.2021.1897679. Epub 2021 Mar 10.

引用本文的文献

1
Immunomodulatory effects of water extract through MAPK and NF-κB signaling in RAW 264.7 cells.水提取物通过丝裂原活化蛋白激酶(MAPK)和核因子κB(NF-κB)信号通路对RAW 264.7细胞的免疫调节作用。
Biotechnol Notes. 2022 Jun 1;3:38-44. doi: 10.1016/j.biotno.2022.05.002. eCollection 2022.
2
A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19.褪黑素对老年 COVID-19 患者线粒体氧化还原活性受损的潜在影响综述
Front Nutr. 2022 Jun 20;9:865321. doi: 10.3389/fnut.2022.865321. eCollection 2022.
3
Identification of bio-active food compounds as potential SARS-CoV-2 PLpro inhibitors-modulators via negative image-based screening and computational simulations.

本文引用的文献

1
Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening.膳食豆甾烷型皂苷作为有前景的新型冠状病毒蛋白酶双靶点定向抑制剂:基于结构的筛选
RSC Adv. 2021 Oct 12;11(53):33380-33398. doi: 10.1039/d1ra05976a. eCollection 2021 Oct 8.
2
Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease.针对 SARS-CoV-2 木瓜蛋白酶样蛋白酶的 COVID-19 治疗的临床批准药物再利用。
Int J Biol Macromol. 2021 Oct 1;188:137-146. doi: 10.1016/j.ijbiomac.2021.07.184. Epub 2021 Aug 6.
3
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay.
通过基于负像的筛选和计算模拟鉴定具有生物活性的食物化合物作为潜在的 SARS-CoV-2 PLpro 抑制剂调节剂。
Comput Biol Med. 2022 Jun;145:105474. doi: 10.1016/j.compbiomed.2022.105474. Epub 2022 Apr 1.
通过高通量筛选与基于翻转绿色荧光蛋白(FlipGFP)的报告基因检测相结合发现严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜样蛋白酶抑制剂
ACS Cent Sci. 2021 Jul 28;7(7):1245-1260. doi: 10.1021/acscentsci.1c00519. Epub 2021 Jun 18.
4
Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulation.通过有监督的分子动力学模拟揭示 SARS-CoV-2 木瓜蛋白酶样蛋白酶已知抑制剂的解结合途径。
PLoS One. 2021 May 19;16(5):e0251910. doi: 10.1371/journal.pone.0251910. eCollection 2021.
5
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs.计算分子对接和虚拟筛选揭示了有前景的抗SARS-CoV-2药物。
Precis Clin Med. 2021 Jan 18;4(1):1-16. doi: 10.1093/pcmedi/pbab001. eCollection 2021 Mar.
6
Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation.利用对接和分子动力学模拟从真菌代谢产物中鉴定出 GRL0617 的结构功能类似物,GRL0617 是唯一一种针对 SARS-CoV2 木瓜样蛋白酶 (PLpro) 的有效抑制剂。
Mol Divers. 2022 Feb;26(1):309-329. doi: 10.1007/s11030-021-10220-8. Epub 2021 Apr 6.
7
ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.新冠病毒木瓜样蛋白酶可拮抗ISG15依赖的传感器MDA5激活,以逃避宿主固有免疫。
Nat Microbiol. 2021 Apr;6(4):467-478. doi: 10.1038/s41564-021-00884-1. Epub 2021 Mar 16.
8
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases.银杏酸和漆树酸是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)半胱氨酸蛋白酶的特异性共价抑制剂。
Cell Biosci. 2021 Feb 28;11(1):45. doi: 10.1186/s13578-021-00564-x.
9
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.将严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白酶作为治疗2019冠状病毒病(COVID-19)的治疗策略所面临的挑战。
ACS Infect Dis. 2021 Jun 11;7(6):1457-1468. doi: 10.1021/acsinfecdis.0c00815. Epub 2021 Feb 11.
10
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.SARS-CoV-2 木瓜蛋白酶样蛋白酶的结构及其与非共价抑制剂的复合物。
Nat Commun. 2021 Feb 2;12(1):743. doi: 10.1038/s41467-021-21060-3.